Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026)

Inogen's (INGN) quarterly Non-Current Deferred Tax Liability came in at $6.6 million in Q1 2026, down 11.3% year-on-year from $7.4 million in Q1 2025, and down 2.62% on a QoQ basis from $6.7 million in Q4 2025.

Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends

Inogen (INGN) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $6.6 million in Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 11.3% year-over-year to $6.6 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 11.3% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 2.86% from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $6.6 million, down from $6.7 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for INGN reached as high as $8.8 million in Q4 2023 and fell as low as $6.6 million in Q1 2026.
  • Historically, Non-Current Deferred Tax Liability has averaged $7.8 million across 5 years, with a median of $8.0 million in 2024.
  • Across the five-year window, Non-Current Deferred Tax Liability climbed 1.52% in 2023 and fell 21.1% in 2024, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $8.7 million in 2022, then grew by 1.52% to $8.8 million in 2023, then fell by 21.1% to $6.9 million in 2024, then retreated by 2.86% to $6.7 million in 2025, then retreated by 2.62% to $6.6 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $6.6 million in Q1 2026, $6.7 million in Q4 2025, and $7.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Inogen 172.68 Mn 62.51 Mn 37.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.57 Mn
Mar 31, 2026 6.57 Mn
Dec 31, 2025 6.75 Mn
Dec 31, 2025 6.75 Mn
Sep 30, 2025 7.89 Mn
Sep 30, 2025 7.89 Mn
Jun 30, 2025 7.95 Mn
Jun 30, 2025 7.95 Mn
Mar 31, 2025 7.41 Mn
Mar 31, 2025 7.41 Mn
Dec 31, 2024 6.95 Mn
Dec 31, 2024 6.95 Mn
Sep 30, 2024 8.38 Mn
Sep 30, 2024 8.38 Mn
Jun 30, 2024 8.07 Mn
Jun 30, 2024 8.07 Mn
Mar 31, 2024 8.15 Mn
Mar 31, 2024 8.15 Mn
Dec 31, 2023 8.81 Mn
Dec 31, 2023 8.81 Mn